Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
17463 | 534 | 27.9 | 52% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2066 | 4824 | BRONCHIECTASIS//PRIMARY CILIARY DYSKINESIA//MUCOCILIARY CLEARANCE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ERDOSTEINE | Author keyword | 30 | 50% | 8% | 43 |
2 | FUDOSTEINE | Author keyword | 20 | 100% | 2% | 9 |
3 | S CARBOXYMETHYL L CYSTEINE | Author keyword | 15 | 73% | 2% | 11 |
4 | CARBOCYSTEINE | Author keyword | 11 | 69% | 2% | 9 |
5 | PHENYLALANINE 4 MONOOXYGENASE | Author keyword | 9 | 83% | 1% | 5 |
6 | CARBOCISTEINE | Author keyword | 4 | 40% | 1% | 8 |
7 | MUCOLYTICS | Author keyword | 4 | 26% | 2% | 13 |
8 | CARBOCYSTEINE LYSINE SALT MONOHYDRATE | Author keyword | 3 | 100% | 1% | 3 |
9 | CAS 84611 23 4 | Author keyword | 3 | 100% | 1% | 3 |
10 | PHENYLALANINE MONOOXYGENASE | Author keyword | 3 | 100% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ERDOSTEINE | 30 | 50% | 8% | 43 | Search ERDOSTEINE | Search ERDOSTEINE |
2 | FUDOSTEINE | 20 | 100% | 2% | 9 | Search FUDOSTEINE | Search FUDOSTEINE |
3 | S CARBOXYMETHYL L CYSTEINE | 15 | 73% | 2% | 11 | Search S+CARBOXYMETHYL+L+CYSTEINE | Search S+CARBOXYMETHYL+L+CYSTEINE |
4 | CARBOCYSTEINE | 11 | 69% | 2% | 9 | Search CARBOCYSTEINE | Search CARBOCYSTEINE |
5 | PHENYLALANINE 4 MONOOXYGENASE | 9 | 83% | 1% | 5 | Search PHENYLALANINE+4+MONOOXYGENASE | Search PHENYLALANINE+4+MONOOXYGENASE |
6 | CARBOCISTEINE | 4 | 40% | 1% | 8 | Search CARBOCISTEINE | Search CARBOCISTEINE |
7 | MUCOLYTICS | 4 | 26% | 2% | 13 | Search MUCOLYTICS | Search MUCOLYTICS |
8 | CARBOCYSTEINE LYSINE SALT MONOHYDRATE | 3 | 100% | 1% | 3 | Search CARBOCYSTEINE+LYSINE+SALT+MONOHYDRATE | Search CARBOCYSTEINE+LYSINE+SALT+MONOHYDRATE |
9 | CAS 84611 23 4 | 3 | 100% | 1% | 3 | Search CAS+84611+23+4 | Search CAS+84611+23+4 |
10 | PHENYLALANINE MONOOXYGENASE | 3 | 100% | 1% | 3 | Search PHENYLALANINE+MONOOXYGENASE | Search PHENYLALANINE+MONOOXYGENASE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CARBOCYSTEINE | 32 | 88% | 3% | 15 |
2 | S CARBOXYMETHYLCYSTEINE | 27 | 78% | 3% | 18 |
3 | LYSINE SALT MONOHYDRATE | 23 | 86% | 2% | 12 |
4 | CARBOCISTEINE | 22 | 81% | 2% | 13 |
5 | CARBOXYMETHYL L CYSTEINE | 16 | 51% | 4% | 23 |
6 | POOR SULFOXIDATION | 11 | 100% | 1% | 6 |
7 | CARBOCYSTEINE LYSINE | 8 | 100% | 1% | 5 |
8 | MOTORNEURON DISEASE | 8 | 100% | 1% | 5 |
9 | EXACERBATION RATE | 6 | 71% | 1% | 5 |
10 | IODINATED GLYCEROL | 6 | 53% | 1% | 8 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review | 2001 | 96 | 20 | 70% |
Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease | 2010 | 8 | 29 | 79% |
Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease | 2004 | 109 | 81 | 37% |
Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease | 2006 | 16 | 27 | 78% |
Environmental toxicity, redox signaling and lung inflammation: The role of glutathione | 2009 | 88 | 149 | 15% |
Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease | 2012 | 4 | 36 | 69% |
Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: Discordant in vitro and in vivo dose-effects: A review | 2007 | 93 | 76 | 18% |
Erdosteine: its relevance in COPD treatment | 2009 | 8 | 26 | 62% |
Pharmacological antioxidant strategies as therapeutic interventions for COPD | 2012 | 21 | 170 | 18% |
S-Carboxymethyl-L-cysteine | 2012 | 3 | 91 | 53% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INNOVAT MED SCI | 2 | 67% | 0.4% | 2 |
2 | STATE P DISGUANGZHOU P DIS | 1 | 50% | 0.4% | 2 |
3 | SORA | 1 | 13% | 1.3% | 7 |
4 | P PHARMACOL | 1 | 11% | 1.1% | 6 |
5 | DIPARTIMENTO CARDIOVASC TORAC | 1 | 50% | 0.2% | 1 |
6 | FAMILY PRACTICES | 1 | 50% | 0.2% | 1 |
7 | FDN SALVATORE MAUGERI IST SCI MILANO IRCCS | 1 | 50% | 0.2% | 1 |
8 | HEBREW UNIV TEACHING HOSP | 1 | 50% | 0.2% | 1 |
9 | POST P DIS | 1 | 50% | 0.2% | 1 |
10 | PROGRAM BIOMED SCI 21 | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000224297 | AMBROXOL//BROMHEXINE//AMBROXOL HYDROCHLORIDE |
2 | 0.0000162237 | RHDNASE//DORNASE ALFA//MUCUS VISCOELASTICITY |
3 | 0.0000149131 | ESAPRAZOLE//EPOMEDIOL//5 1 2 DIHYDROXY 1 METHYLETHYL 2 METHYL 2 CYCLOHEXEN 1 ONE |
4 | 0.0000121752 | TIOPRONIN//CAPTOPRIL DETERMINATION//PENICILLAMINE |
5 | 0.0000082362 | CARDIOMYOPATHY DILATED MYOCARDITIS//LYMPHOCYTES FUNCTION INTRACELLULAR METABOLISM// |
6 | 0.0000079150 | SUSCEPTIBILITY TO INFECTIONS//HKLIN SYLT KINDER JUGENDLICHE//MED KLIMATOL |
7 | 0.0000067309 | OXIDATIVE DAMAGE OF PROTEINS//DIPARTIMENTO AREA SERV DIAGNOST//BREATH PENTANE |
8 | 0.0000066772 | OXYGEN CHEM//ADULT INTENS CARE MED BURNS//HOSP MEAUX |
9 | 0.0000066545 | ASIALO GM1 POSITIVE CELL//AZOCASEIN HYDROLYSIS//EXPTL ALLERGY |
10 | 0.0000066105 | MUC5AC//AIRWAY MUCIN//MUC5B |